Mablink Bioscience

📍 LYON, France🗓 Founded 2018👥 34 employees💰 Last funded Sep 2022
Biotechnology Research🌐 mablink.com
Website LinkedIn
Mablink Bioscience is a French biotechnology company that is actively involved in the fight against cancer by bringing disruptive therapeutic solutions. With its Antibody-Drug Conjugates (ADC) masking technology, Mablink Bioscience aims to dramatically improve the efficiency of ADC therapies and accelerate the development of new treatments. Based in Lyon, where it is developing an unprecedented innovation center, Mablink currently has around 30 employees with diverse backgrounds.
2
Total investors
0
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
2
Frequently asked questions
Who invested in Mablink Bioscience?
Mablink Bioscience has 2 investors on record on gritt.io, 1 mid-stage.
When did Mablink Bioscience last raise funding?
The most recent investment in Mablink Bioscience recorded on gritt.io was in September 2022.
When was Mablink Bioscience founded?
Mablink Bioscience was founded in 2018.
What industry is Mablink Bioscience in?
Mablink Bioscience operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Mablink Bioscience based?
Mablink Bioscience is headquartered in LYON, France.